Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Trevi Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q4 2022
- Shares held
- 43.5M
- +276.6K (+0.6%) vs. Q4 2022
- Total value
- $80.4M
- −$2.94M (−3.5%) vs. Q4 2022
- New holders
- 3
- 11 more added
- Sold out
- 4
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $21.0M | 1.45% | −2,7980.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 6,663,590 | $12.3M | 0.89% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 5,696,515 | $10.5M | 1.81% | 00.0% | Unchanged |
| Rubric Capital Management LP | 5,684,420 | $10.5M | 0.42% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,400,000 | $8.14M | 0.04% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,050,022 | $5.64M | 1.10% | 00.0% | Unchanged |
| MAI Capital Management | 1,600,415 | $2.96M | 0.05% | −120,261−7.0% | Reduced |
| Vanguard Group Inc | 1,499,751 | $2.77M | 0.00% | +60,158+4.2% | Added |
| Silverarc Capital Management, LLC | 885,924 | $1.64M | 0.74% | +118,293+15.4% | Added |
| Opaleye Management Inc. | 835,800 | $1.55M | 0.46% | +350,800+72.3% | Added |
| Geode Capital Management, LLC | 248,293 | $459.3K | 0.00% | +36,746+17.4% | Added |
| Renaissance Technologies LLC | 237,400 | $439.0K | 0.00% | −80,600−25.3% | Reduced |
| Tejara Capital Ltd | 190,218 | $351.9K | 0.18% | +40,260+26.8% | Added |
| Bridgeway Capital Management, LLC | 188,400 | $348.5K | 0.01% | −20,000−9.6% | Reduced |
| State Street Corp | 99,542 | $184.2K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 93,500 | $173.0K | 0.06% | 00.0% | Unchanged |
| J. Goldman & Co LP | 89,188 | $165.0K | 0.01% | 00.0% | Unchanged |
| Innovis Asset Management LLC | 87,369 | $161.6K | 0.07% | −84−0.1% | Reduced |
| Trust Co of Toledo NA | 83,000 | $153.6K | 0.03% | +83,000 | New |
| BlackRock Inc. | 82,245 | $152.2K | 0.00% | +1,474+1.8% | Added |
| Citadel Advisors LLC | 71,655 | $132.6K | 0.00% | +27,439+62.1% | Added |
| Northern Trust Corp | 64,183 | $118.7K | 0.00% | +10,068+18.6% | Added |
| Millennium Management LLC | 59,628 | $110.0K | 0.00% | −97,996−62.2% | Reduced |
| Atom Investors LP | 34,471 | $63.8K | 0.03% | +9,095+35.8% | Added |
| United Bank | 28,450 | $52.6K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 27,666 | $51.2K | 0.00% | +27,666 | New |
| Bailard, Inc. | 21,200 | $39.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,098 | $26.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 12,928 | $23.9K | 0.00% | −15,725−54.9% | Reduced |
| Charles Schwab Investment Management Inc | 12,557 | $23.2K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 11,474 | $21.2K | 0.00% | +11,474 | New |
| LPL Financial LLC | 10,000 | $18.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,580 | $14.0K | 0.00% | +4,489+145.2% | Added |
| Morgan Stanley | 384 | $710 | 0.00% | −55−12.5% | Reduced |
| Wells Fargo & Company | 265 | $490 | 0.00% | +4+1.5% | Added |
| Simplex Trading, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −152,300−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,995−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −92−100.0% | Sold out |